Clover Biopharmaceuticals Reports Encouraging Phase 2 Data for New Respiratory Vaccine in Older Adults #Australia #Sydney #RSV_Vaccine #Clover #hMPV_Vaccine
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialClover Biopharmaceuticals Reports Encouraging Phase 2 Data for New Respiratory Vaccine in Older Adults #Australia #Sydney #RSV_Vaccine #Clover #hMPV_Vaccine